
SKIN Stock Forecast & Price Target
SKIN Analyst Ratings
Bulls say
SkinHealth Systems is a global medical aesthetics company that offers a diverse portfolio of clinically validated solutions, including the popular brands Hydrafacial and SkinStylus. With a highly recurring revenue model and a growing active installed base, the company is well-positioned for sustained growth. However, capital constraints, lower consumables utilization, and a challenging market environment may continue to hinder short-term performance. The company should focus on utilizing boosters, improving treatment frequency, and expanding its global footprint to drive future growth.
Bears say
SkinHealth Systems is facing intensified competition in its market, leading to pressure on sales and profitability. Despite management's execution on strategic priorities, the guidance for the current quarter and full fiscal year implies continued weakness in revenue, indicating limited evidence of a sustainable return to growth. Additionally, ongoing litigation and an SEC investigation may weigh on the company's cash flow and financial performance going forward. As a result, the financial analyst has a negative outlook on the company's stock.
This aggregate rating is based on analysts' research of The Beauty Health Company and is not a guaranteed prediction by Public.com or investment advice.
SKIN Analyst Forecast & Price Prediction
Start investing in SKIN
Order type
Buy in
Order amount
Est. shares
0 shares